Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies-Reference-Cited by-同舟云学术

Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies

Published:2009 Issue:3 Volume:219 Page:177-186
ISSN:0040-8727
Container-title:The Tohoku Journal of Experimental Medicine
language:en
Short-container-title:Tohoku J. Exp. Med.

Author:

Rybak Leonard P¹²,Mukherjea Debashree¹²,Jajoo Sarvesh²,Ramkumar Vickram²

Affiliation:

1. Department of Surgery, Southern Illinois University School of Medicine

2. Department of Pharmacology, Southern Illinois University School of Medicine

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.jstage.jst.go.jp/article/tjem/219/3/219_3_177/_pdf

Reference99 articles.

1. Allen, G.C., Tiu, C., Koike, K., Ritchey, A.K., Kurs-Lasky, M. & Wax, M.K. (1998) Transient evoked otoacoustic emissions in children after cisplatin chemotherapy. Otolaryngol. Head Neck Surg., 118, 584-588.

2. NOX3, a Superoxide-generating NADPH Oxidase of the Inner Ear

3. Barahmani, N., Carpentieri, S., Li, X.N., Wang, T., Cao, Y., Howe, L., Kilburn, L., Chintagumpala, M., Lau, C. & Okcu, M.F. (2009) Glutathione S-transferase M1 and T1 polymorphinsms may predict adverse effects after therapy in children with medulloblastoma. Neuro. Oncol., 11, 292-300.

4. Bertolini, P., Lassalle, M., Mercier, G., Raquin, M.A., Izzi, G., Corradini, N. & Hartmann, O. (2004) Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss. J. Pediatr. Hematol. Oncol., 26, 649-655.

5. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer

Cited by 307 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing biocompatibility of the brain-machine interface: A review;Bioactive Materials;2024-12

2. Chemoradiotherapy Induced Hearing Impairment in Head and Neck Malignancies;Indian Journal of Otolaryngology and Head & Neck Surgery;2024-09-02

3. Proton pump inhibitors may increase the risk of cisplatin-induced acute kidney injury in patients with nasopharyngeal carcinoma: a prospective cohort study;Scientific Reports;2024-08-13

4. The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy;Cancer Medicine;2024-08

5. Harmonization of the Upfront Osteosarcoma Treatment Paradigm for Adolescents and Young Adults;Journal of Adolescent and Young Adult Oncology;2024-07-15